HIV-1 DNA predicts disease progression and post-treatment virological control

James P. Williams; Jacob Hurst; Wolfgang Stöhr; Nicola Robinson; Helen Brown; Martin Fisher; Sabine Kinloch; David Cooper; Mauro Schechter; Giuseppe Tambussi; Sarah Fidler; Mary Carrington; Abdel Babiker; Jonathan Weber; Kersten K. Koelsch; Anthony D. Kelleher; Rodney E. Phillips; John Frater; SPARTACTrial Investigators

doi:10.7554/eLife.03821

HIV-1 DNA predicts disease progression and post-treatment virological control

James P. Williams, Jacob Hurst, Wolfgang Stöhr, Nicola Robinson, Helen Brown, Martin Fisher, Sabine Kinloch, David Cooper, Mauro Schechter, Giuseppe Tambussi, Sarah Fidler, Mary Carrington, Abdel Babiker, Jonathan Weber, Kersten K. Koelsch, Anthony D. Kelleher, Rodney E. Phillips, John Frater, SPARTACTrial Investigators

IRCCS Ospedale San Raffaele

Research output: Contribution to journal › Article › peer-review

Abstract

In HIV-1 infection, a population of latently infected cells facilitates viral persistence despite antiretroviral therapy (ART). With the aim of identifying individuals in whom ART might induce a period of viraemic control on stopping therapy, we hypothesised that quantification of the pool of latently infected cells in primary HIV-1 infection (PHI) would predict clinical progression and viral replication following ART. We measured HIV-1 DNA in a highly characterised randomised population of individuals with PHI. We explored associations between HIV-1 DNA and immunological and virological markers of clinical progression, including viral rebound in those interrupting therapy. In multivariable analyses, HIV-1 DNA was more predictive of disease progression than plasma viral load and, at treatment interruption, predicted time to plasma virus rebound. HIV-1 DNA may help identify individuals who could safely interrupt ART in future HIV-1 eradication trials.

Original language	English
Pages (from-to)	e03821
Journal	eLife
Volume	3
DOIs	https://doi.org/10.7554/eLife.03821
Publication status	Published - 2014

Keywords

antiretroviral therapy
cure
HIV-1
human
human biology
infectious disease
medicine
microbiology
primary infection
reservoir

ASJC Scopus subject areas

Neuroscience(all)
Medicine(all)
Immunology and Microbiology(all)
Biochemistry, Genetics and Molecular Biology(all)

Access to Document

10.7554/eLife.03821

Cite this

Williams, J. P., Hurst, J., Stöhr, W., Robinson, N., Brown, H., Fisher, M., Kinloch, S., Cooper, D., Schechter, M., Tambussi, G., Fidler, S., Carrington, M., Babiker, A., Weber, J., Koelsch, K. K., Kelleher, A. D., Phillips, R. E., Frater, J., & SPARTACTrial Investigators (2014). HIV-1 DNA predicts disease progression and post-treatment virological control. eLife, 3, e03821. https://doi.org/10.7554/eLife.03821

HIV-1 DNA predicts disease progression and post-treatment virological control. / Williams, James P.; Hurst, Jacob; Stöhr, Wolfgang; Robinson, Nicola; Brown, Helen; Fisher, Martin; Kinloch, Sabine; Cooper, David; Schechter, Mauro; Tambussi, Giuseppe; Fidler, Sarah; Carrington, Mary; Babiker, Abdel; Weber, Jonathan; Koelsch, Kersten K.; Kelleher, Anthony D.; Phillips, Rodney E.; Frater, John; SPARTACTrial Investigators.

In: eLife, Vol. 3, 2014, p. e03821.

Research output: Contribution to journal › Article › peer-review

Williams, JP, Hurst, J, Stöhr, W, Robinson, N, Brown, H, Fisher, M, Kinloch, S, Cooper, D, Schechter, M, Tambussi, G, Fidler, S, Carrington, M, Babiker, A, Weber, J, Koelsch, KK, Kelleher, AD, Phillips, RE, Frater, J & SPARTACTrial Investigators 2014, 'HIV-1 DNA predicts disease progression and post-treatment virological control', eLife, vol. 3, pp. e03821. https://doi.org/10.7554/eLife.03821

Williams, James P. ; Hurst, Jacob ; Stöhr, Wolfgang ; Robinson, Nicola ; Brown, Helen ; Fisher, Martin ; Kinloch, Sabine ; Cooper, David ; Schechter, Mauro ; Tambussi, Giuseppe ; Fidler, Sarah ; Carrington, Mary ; Babiker, Abdel ; Weber, Jonathan ; Koelsch, Kersten K. ; Kelleher, Anthony D. ; Phillips, Rodney E. ; Frater, John ; SPARTACTrial Investigators. / HIV-1 DNA predicts disease progression and post-treatment virological control. In: eLife. 2014 ; Vol. 3. pp. e03821.

@article{6d65ead738d74dfba5229eca6d02399a,

title = "HIV-1 DNA predicts disease progression and post-treatment virological control",

abstract = "In HIV-1 infection, a population of latently infected cells facilitates viral persistence despite antiretroviral therapy (ART). With the aim of identifying individuals in whom ART might induce a period of viraemic control on stopping therapy, we hypothesised that quantification of the pool of latently infected cells in primary HIV-1 infection (PHI) would predict clinical progression and viral replication following ART. We measured HIV-1 DNA in a highly characterised randomised population of individuals with PHI. We explored associations between HIV-1 DNA and immunological and virological markers of clinical progression, including viral rebound in those interrupting therapy. In multivariable analyses, HIV-1 DNA was more predictive of disease progression than plasma viral load and, at treatment interruption, predicted time to plasma virus rebound. HIV-1 DNA may help identify individuals who could safely interrupt ART in future HIV-1 eradication trials. ",

keywords = "antiretroviral therapy, cure, HIV-1, human, human biology, infectious disease, medicine, microbiology, primary infection, reservoir",

author = "Williams, {James P.} and Jacob Hurst and Wolfgang St{\"o}hr and Nicola Robinson and Helen Brown and Martin Fisher and Sabine Kinloch and David Cooper and Mauro Schechter and Giuseppe Tambussi and Sarah Fidler and Mary Carrington and Abdel Babiker and Jonathan Weber and Koelsch, {Kersten K.} and Kelleher, {Anthony D.} and Phillips, {Rodney E.} and John Frater and {SPARTACTrial Investigators}",

year = "2014",

doi = "10.7554/eLife.03821",

language = "English",

volume = "3",

pages = "e03821",

journal = "eLife",

issn = "2050-084X",

publisher = "eLife Sciences Publications",

}

TY - JOUR

T1 - HIV-1 DNA predicts disease progression and post-treatment virological control

AU - Williams, James P.

AU - Hurst, Jacob

AU - Stöhr, Wolfgang

AU - Robinson, Nicola

AU - Brown, Helen

AU - Fisher, Martin

AU - Kinloch, Sabine

AU - Cooper, David

AU - Schechter, Mauro

AU - Tambussi, Giuseppe

AU - Fidler, Sarah

AU - Carrington, Mary

AU - Babiker, Abdel

AU - Weber, Jonathan

AU - Koelsch, Kersten K.

AU - Kelleher, Anthony D.

AU - Phillips, Rodney E.

AU - Frater, John

AU - SPARTACTrial Investigators

PY - 2014

Y1 - 2014

N2 - In HIV-1 infection, a population of latently infected cells facilitates viral persistence despite antiretroviral therapy (ART). With the aim of identifying individuals in whom ART might induce a period of viraemic control on stopping therapy, we hypothesised that quantification of the pool of latently infected cells in primary HIV-1 infection (PHI) would predict clinical progression and viral replication following ART. We measured HIV-1 DNA in a highly characterised randomised population of individuals with PHI. We explored associations between HIV-1 DNA and immunological and virological markers of clinical progression, including viral rebound in those interrupting therapy. In multivariable analyses, HIV-1 DNA was more predictive of disease progression than plasma viral load and, at treatment interruption, predicted time to plasma virus rebound. HIV-1 DNA may help identify individuals who could safely interrupt ART in future HIV-1 eradication trials.

AB - In HIV-1 infection, a population of latently infected cells facilitates viral persistence despite antiretroviral therapy (ART). With the aim of identifying individuals in whom ART might induce a period of viraemic control on stopping therapy, we hypothesised that quantification of the pool of latently infected cells in primary HIV-1 infection (PHI) would predict clinical progression and viral replication following ART. We measured HIV-1 DNA in a highly characterised randomised population of individuals with PHI. We explored associations between HIV-1 DNA and immunological and virological markers of clinical progression, including viral rebound in those interrupting therapy. In multivariable analyses, HIV-1 DNA was more predictive of disease progression than plasma viral load and, at treatment interruption, predicted time to plasma virus rebound. HIV-1 DNA may help identify individuals who could safely interrupt ART in future HIV-1 eradication trials.

KW - antiretroviral therapy

KW - cure

KW - HIV-1

KW - human

KW - human biology

KW - infectious disease

KW - medicine

KW - microbiology

KW - primary infection

KW - reservoir

UR - http://www.scopus.com/inward/record.url?scp=84925375640&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84925375640&partnerID=8YFLogxK

U2 - 10.7554/eLife.03821

DO - 10.7554/eLife.03821

M3 - Article

C2 - 25217531

AN - SCOPUS:84925375640

VL - 3

SP - e03821

JO - eLife

JF - eLife

SN - 2050-084X

ER -

HIV-1 DNA predicts disease progression and post-treatment virological control

Abstract

Keywords

ASJC Scopus subject areas

Access to Document

Other files and links

Fingerprint

Cite this